GB201416868D0 - Mass spectral analysis of urine and other bodily fluids for the detection of cancer biomarkers - Google Patents

Mass spectral analysis of urine and other bodily fluids for the detection of cancer biomarkers

Info

Publication number
GB201416868D0
GB201416868D0 GBGB1416868.6A GB201416868A GB201416868D0 GB 201416868 D0 GB201416868 D0 GB 201416868D0 GB 201416868 A GB201416868 A GB 201416868A GB 201416868 D0 GB201416868 D0 GB 201416868D0
Authority
GB
United Kingdom
Prior art keywords
urine
detection
spectral analysis
bodily fluids
mass spectral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1416868.6A
Other versions
GB2530521A (en
GB2530521B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ILES RAYMOND K AND BUTLER STEPHEN A
Original Assignee
ILES RAYMOND K AND BUTLER STEPHEN A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ILES RAYMOND K AND BUTLER STEPHEN A filed Critical ILES RAYMOND K AND BUTLER STEPHEN A
Priority to GB1416868.6A priority Critical patent/GB2530521B/en
Publication of GB201416868D0 publication Critical patent/GB201416868D0/en
Publication of GB2530521A publication Critical patent/GB2530521A/en
Application granted granted Critical
Publication of GB2530521B publication Critical patent/GB2530521B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Reproductive Health (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
GB1416868.6A 2014-09-24 2014-09-24 Mass spectral analysis of patient samples for the detection of the human chorionic gonadotropin Active GB2530521B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1416868.6A GB2530521B (en) 2014-09-24 2014-09-24 Mass spectral analysis of patient samples for the detection of the human chorionic gonadotropin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1416868.6A GB2530521B (en) 2014-09-24 2014-09-24 Mass spectral analysis of patient samples for the detection of the human chorionic gonadotropin

Publications (3)

Publication Number Publication Date
GB201416868D0 true GB201416868D0 (en) 2014-11-05
GB2530521A GB2530521A (en) 2016-03-30
GB2530521B GB2530521B (en) 2020-06-10

Family

ID=51869420

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1416868.6A Active GB2530521B (en) 2014-09-24 2014-09-24 Mass spectral analysis of patient samples for the detection of the human chorionic gonadotropin

Country Status (1)

Country Link
GB (1) GB2530521B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115684606A (en) * 2022-10-21 2023-02-03 南方医科大学珠江医院 M protein detection method

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201808529D0 (en) * 2018-05-24 2018-07-11 Binding Site Group Ltd Identification of immunoglobulins usong mass spectrometry

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2702494B1 (en) * 1993-03-11 1995-06-09 Lafon Labor Diagnostic kit for cancer secreting hCG or fragments of hCG and vaccine intended for immunotherapy of such cancer.
CA2602088C (en) * 2005-03-11 2021-07-27 Ciphergen Biosystems, Inc. Biomarkers for ovarian cancer and endometrial cancer
WO2009086297A2 (en) * 2007-12-21 2009-07-09 The Board Of Regents Of The University Of Oklahoma Identification of biomarkers in biological samples and methods of unsing same
US20110065605A1 (en) * 2008-05-14 2011-03-17 Eth Zurich Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115684606A (en) * 2022-10-21 2023-02-03 南方医科大学珠江医院 M protein detection method
CN115684606B (en) * 2022-10-21 2023-11-28 南方医科大学珠江医院 M protein detection method

Also Published As

Publication number Publication date
GB2530521A (en) 2016-03-30
GB2530521B (en) 2020-06-10

Similar Documents

Publication Publication Date Title
HK1245345A1 (en) Multigene analysis of tumor samples
HK1246828A1 (en) Biomarker panel for the detection of cancer
EP3171765A4 (en) Collection and analysis of data for diagnostic purposes
EP3111228A4 (en) Urinalysis device and dry reagent for quantitative urinalysis
EP3232198A4 (en) Biomarker for diagnosis of hepatoma and use thereof
IL254687B1 (en) Biosensor system for the rapid detection of analytes
EP3204008A4 (en) Use of biomarkers for predicting clinical sensitivity to cancer treatment
EP3372686A4 (en) Biomarker for detection of lung adenocarcinoma and use thereof
HK1245060A1 (en) Determination of fertility potential from the oxidation-reduction potential of a biological sample
HK1250778A1 (en) Analyte detection and methods therefor
EP3201312A4 (en) Methods and devices relating to the detection of oral cancer biomarkers
GB201820795D0 (en) Analysis of bodily fluids using infrared spectroscopy for the diagnosis and/or prognosis of cancer
EP3134545A4 (en) Method and biomarker for detecting cancer
EP3359115A4 (en) Bodily fluid sample collection and transport
HK1243434A1 (en) Igf-1r antibody and its use for the diagnosis of cancer
SG11201608473RA (en) Devices and kits for measuring biological results
GB201619808D0 (en) Biomarkers for the prognosis and diagnosis of cancer
GB201416868D0 (en) Mass spectral analysis of urine and other bodily fluids for the detection of cancer biomarkers
GB2538113B (en) Analyte sensing probe
EP3189332A4 (en) Biomarkers for detection of breast cancer
HK1248730A1 (en) Igf-1r antibody and its use for the diagnosis of cancer
GB201414913D0 (en) Determination and analysis of biomarkers in clinical samples
GB201410956D0 (en) Determination and analysis of biomarkers in clinical samples

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20160503 AND 20160504